Varvarigou A D, Archimandritis S C, Sekeri-Pataryas K, Sourlingas T G, Sivolapenko G, Paschali E
Institute of Radiodiagnostics, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Greece.
Nucl Med Commun. 1996 Jan;17(1):80-8. doi: 10.1097/00006231-199601000-00014.
The aim of this study was to make a comparative evaluation of a direct and an indirect method for the labelling of anti-CEA with technetium-99m (99Tcm). With the direct method, disulphide bridges were cleaved by the use of 2-mercaptoethanol as reductant, whereas with the indirect method, the antibody was coupled to 2-iminothiolane. In both cases, a preformed intermediate chelate was used for 99Tcm exchange. The radiochemical and radiobiological behaviour of the 99Tcm-labelled species were studied. Furthermore, the influence of the labelling systems on the integrity of monoclonal antibodies, as well as the ability of 99Tcm-anti-CEA to tag onto human cancer cells, was investigated for the two labelling systems. Both methods showed a high labelling yield and resulted in immunoreactive and stable derivatives. However, detailed electrophoretical and radiochemical data, as well as the cysteine challenge trial, indicated relatively greater stability for the 2-mercaptoethanol reduction procedure.